ストックスクリーナーアプリを入手
10.25
0.28%
0.5699
アフターアワーズ：
10.30
0.0499
+0.49%
前日終値:
$10.82
開ける：
$11
24時間の取引高:
7,422
Relative Volume:
0.68
時価総額：
$61.51M
収益：
$503.40K
当期純損益:
$9.17M
株価収益率:
5.6602
EPS:
1.8109
ネットキャッシュフロー:
$-604.40K
1週間 パフォーマンス:
-4.49%
1か月 パフォーマンス:
+5.85%
6か月 パフォーマンス:
-17.18%
1年 パフォーマンス:
+40.18%
1日の値動き範囲:
$10.25
$11.00
1週間の範囲:
$10.20
$11.74
52週間の値動き範囲:
$7.73
$14.76
Daxor Corporation Stock (DXR) Company Profile
名前
Daxor Corporation
セクター
電話
212-330-8500
住所
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.55 | 63.05M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
436.65 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.69 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.10 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-05-16 | 開始されました | Ascendiant Capital Markets | Buy |
Daxor Corporation (DXR) 最新ニュース
Daxor Corporation (DXR) Holds Steady at $10.82 as Shares Test Key Support ZoneOpen Trading Community - Newser
DXR Q3 2007 Earnings: Significant Earnings Beat Driven by Strong Operational PerformanceEarnings Sentiment Score - Newser
Daxor Corporation (DXR) Q3 2007 Earnings: Landmark EPS Beat Lifts Sentiment Despite No Revenue DisclosureSocial Signal Watchlist - Newser
Number of shareholders of Daxor Corporation – FWB:DX5 - TradingView
DXR Daxor Q3 results shatter estimates with 3257 EPS surprise 3835 revenue surge driving 3 stock gainCommunity Sell Signals - Newser
How (DXR) Movements Inform Risk Allocation Models - Stock Traders Daily
TradingKey - TradingKey
Daxor (DXR) reports quarterly earnings as company outlines strategic priorities amid market uncertainty.Social Signal Watchlist - Newser
The long term thesis for Daxor (DXR) in plain sight (-4.73%) 2026-05-08Diagonal Spread Trade - Newser
Trading Systems Reacting to (DXR) Volatility - Stock Traders Daily
What Daxor (DXR) is doing that could pay off big later (Climbs) 2026-05-05Investment Community Signals - newser.com
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis - The Globe and Mail
5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. - marketscreener.com
How Daxor Corporation (DXR) Affects Rotational Strategy Timing - Stock Traders Daily
(DXR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
RSI Check: What is the long term forecast for Daxor Corporation stockEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
CEO Moves: Is Daxor Corporation stock risky to hold now2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
Insider Buying: Michael Feldschuh Acquires Additional Shares of Daxor Corp (DXR) - GuruFocus
Daxor CEO Feldschuh buys $9,070 in shares By Investing.com - Investing.com South Africa
Daxor CEO Feldschuh buys $9,070 in shares - Investing.com
DAXOR (DXR) CEO Michael Feldschuh adds 1,000 shares in open-market buy - Stock Titan
Daxor launches blood volume testing program in Ohio By Investing.com - Investing.com South Africa
Daxor Corporation Expands Customer Footprint With New BVA Program At High-Volume Ohio Cardiology Center - marketscreener.com
Daxor launches blood volume testing program in Ohio - Investing.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center - GlobeNewswire
Income Plays: Is Daxor Corporation vulnerable to short sellers2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Can Daxor (DXR) Stock Double in 2026 | Price at $9.16, Down 5.52%RSI Oversold Stocks - Newser
[N-CEN/A] DAXOR CORP SEC Filing - Stock Titan
Insider Buying: Robert Michel Acquires Shares of Daxor Corp (DXR) - GuruFocus
Michel, Daxor CFO, buys $9,900 in DXR stock - Investing.com
Michel, Daxor CFO, buys $9,900 in DXR stock By Investing.com - Investing.com India
DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy - Stock Titan
DXR PE Ratio & Valuation, Is DXR Overvalued - Intellectia AI
Setup Watch: Will Daxor Corporation stock go up in YEARNew Guidance & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Earnings Risk: What is the target price for Daxor Corporation stock2026 Biggest Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 - Bitget
Daxor’s Blood Volume Analysis Metric Validated as Uniquely - GlobeNewswire
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia
Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan
Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire
Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks
Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus
Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com
Daxor Corporation (DXR) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
0.08%
大文字化:
|
ボリューム (24 時間):